The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
II-73, has the potential to restore memory and cognitive function in a mouse model of Alzheimer's disease. The study demonstrates that the drug improves memory deficits and reverses brain cell damage, ...
HealthDay on MSN9d
FDA Approves First New Non-Opioid Pain Pill in DecadesThe US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.
Scientists have discovered a potential new drug that could help people with Alzheimer’s disease by improving memory and ...
Federal officials on Thursday approved ... brain that receive nerve signals from different parts of the body. Those chemical interactions also give rise to opioids' addictive effects. Vertex’s ...
It's the first new non-opioid pain pill in ... reach the brain, avoiding opioid risks FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx ...
The FDA approved Journavx ... for post-surgery pain. The drug, developed by Vertex Pharmaceuticals, blocks pain signals before they reach the brain, avoiding opioid-related addiction risks.
(HealthDay News) — The US Food and Drug Administration (FDA) has approved Journavx ... Unlike opioids, which bind to brain receptors to reduce pain but often lead to dependence and addiction ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results